Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-VEGF therapy outcomes in diabetic macular edema
TCTR20230209002Completed
- Sponsor
- Novartis
- Start
- Jan 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in diabetic macular edema (DME), sponsored by Novartis. Started Jan 2016; status: completed.
02
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on TCTR20230209002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230209002.